Skip to main content
OpenTrials

Clinical trial condition

Exocrine Pancreatic Insufficiency (EPI)

Explore clinical trials studying Exocrine Pancreatic Insufficiency (EPI). Study availability and eligibility vary by location and protocol.

7 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Exocrine Pancreatic Insufficiency (EPI) trial results

Recruiting

Phase 2 Study to Assess the Safety and Efficacy of ANG003

NCT07450547

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Cystic Fibrosis (CF), +8 more
Locations
  • Long Beach Memorial Medical Center Long Beach, California, United States
  • Center for Cystic Fibrosis at Keck Medical Center of USC Los Angeles, California, United States
  • National Jewish Health Denver, Colorado, United States
  • University of Florida Gainesville, Florida, United States
View all 26 locations
View Trial Details
Not Yet Recruiting

A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.

NCT07559175

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Cystic Fibrosis (CF), +9 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Keck Hospital of USC Los Angeles, California, United States
  • University of Southern California University Hospital (USCUH) - Internal Medicine Los Angeles, California, United States
  • Advent Health Medical Group Orlando, Florida, United States
View all 30 locations
View Trial Details
Completed

OPTION 2: A Trial to Assess the Safety and Efficacy of MS1819 in Enteric Capsules in Patients With Cystic Fibrosis

NCT04375878

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Cystic Fibrosis (CF), +8 more
Locations
  • Investigator Site 105 Long Beach, California, United States
  • Investigator Site 102 Altamonte Springs, Florida, United States
  • Investigator Site 107 Miami, Florida, United States
  • Investigator Site 101 Glenview, Illinois, United States
View all 15 locations
View Trial Details
Completed

OPTION: A Trial to Assess the Safety & Efficacy of MS1819 in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

NCT03746483

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Cystic Fibrosis (CF), +8 more
Locations
  • Investigator Site 105 Long Beach, California, United States
  • Investigator Site 102 Altamonte Springs, Florida, United States
  • Investigator Site 107 Miami, Florida, United States
  • Investigator Site 101 Glenview, Illinois, United States
View all 14 locations
View Trial Details

Related conditions